aState Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute, Beijing, China bState Key ...

She also tested positive for antibodies against GPCR and PGFR3 (Table 1). Just one day after vaccination, she had developed fever, pain, tingling, hypoesthesia, dysesthesias, and burning paresthesias ...

Of the 23 patients with high-positive (>400 pM) levels, 12 were given immunotherapies, 11 of whom showed a good response. 11 were considered definitely autoimmune, 10 with limbic encephalitis ...

The Defense Forces of Ukraine have eliminated another 1,300 Russian soldiers and destroyed 4 tanks, 36 artillery systems, 1 multiple launch rocket system (MLRS), and 1 enemy air defense system ...

Robert Prevost has been elected as pope following the death of Pope Francis last month – but he has previously expressed anti-LGBTQ+ views. Prevost, who is the first American to hold the position of ...

China’s Ministry of Commerce has announced anti-dumping duties on cypermethrin imports from India, effective immediately. The duties are set to last for five years. The decision follows a year-long ...

SEATTLE — For the second night in a row, protesters showed up on the University of Washington campus, this time to denounce an appearance by a well-known anti-trans ... caused $1 million in ...

Positive samples from the binding ... of normal during the study (IgM 6 vs 4; IgG 3 vs 1; IgA, no patients, respectively). No patients treated with ofatumumab developed detectable anti-ofatumumab ...

today announced positive 24-week results from its completed Phase 1/2a trial of PER-001, a first in class endothelin antagonist intravitreal implant for glaucoma. Steven Mansberger, MD, MPH, Chief of ...

Will Jo Adell play tonight against Detroit Tigers? Latest update on the Los Angeles Angels star’s injury report (May 1, 2025) (Image Source: Getty) Is Jo Adell clear to be in action against the ...

Based on these positive ... of anti-TL1A antibodies, designed to block the interaction between the DR3 receptor and its ligand TL1A, have reduced disease activity in patients with UC and CD in ...